|
NECAP2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.24369999998653E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.91569999974384E-07 |
| Normal-vs-Stage2 |
8.037400E-01 |
| Normal-vs-Stage3 |
3.6742000000034E-05 |
| Normal-vs-Stage4 |
2.355100E-03 |
| Stage1-vs-Stage2 |
1.021420E-04 |
| Stage1-vs-Stage3 |
9.274600E-01 |
| Stage1-vs-Stage4 |
5.252800E-01 |
| Stage2-vs-Stage3 |
1.499930E-03 |
| Stage2-vs-Stage4 |
1.184120E-02 |
| Stage3-vs-Stage4 |
6.409800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.48809999989119E-07 |
| Normal-vs-AfricanAmerican |
1.5421000000293E-06 |
| Normal-vs-Asian |
1.753220E-04 |
| Caucasian-vs-AfricanAmerican |
1.319160E-01 |
| Caucasian-vs-Asian |
9.672800E-01 |
| AfricanAmerican-vs-Asian |
2.431400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.776200E-04 |
| Normal-vs-Female |
8.66599999982398E-07 |
| Male-vs-Female |
4.618200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.85920000506101E-08 |
| Normal-vs-Age(41-60Yrs) |
5.56699999999521E-05 |
| Normal-vs-Age(61-80Yrs) |
3.871600E-02 |
| Normal-vs-Age(81-100Yrs) |
3.843600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.409900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.681800E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.682800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.642610E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.963600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.327200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.714200E-01 |
| Classical-VS-Follicular |
6.63236132680822E-12 |
| Classical-VS-Other |
2.995600E-02 |
| Classical-VS-Normal |
7.42890005067665E-09 |
| Tall-VS-Follicular |
5.2810999995323E-07 |
| Tall-VS-Other |
4.154500E-02 |
| Tall-VS-Normal |
5.86849999999473E-05 |
| Follicular-VS-Other |
6.159200E-01 |
| Follicular-VS-Normal |
3.397600E-01 |
| Other-VS-Normal |
8.626600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.407500E-04 |
| Normal-vs-N1 |
8.503600E-02 |
| N0-vs-N1 |
2.717600E-01 |
|
|
